Gene/Genome Synthesis & Sequencing Related News

Thermo Fisher Scientific Releases Gene Synthesis and Genome Editing Products in China

As the market for synthetic biology grows, customers can now access proven GeneArt products CARLSBAD, California, Sept. 4, 2018 /PRNewswire/ -- Asia Pacific is predicted to be the fastest growing market for synthetic biology from 2018 to 2025, driving increased [...]

Molecular Assemblies Expands Patent Portfolio in Enzymatic DNA Synthesis

SAN DIEGO, September 18, 2018 — Molecular Assemblies, Inc. today announced the recent award of three patents, bringing the total to eight issued patents protecting the company’s proprietary enzymatic DNA synthesis technology in the United States and Europe. The three [...]

Evonetix makes key appointments to support development of novel gene synthesis technology

CAMBRIDGE, UK, 18 September 2018 – EVONETIX LTD (‘Evonetix’), the company pioneering an innovative approach to scalable and high-fidelity gene synthesis, announced today that it has expanded its team three-fold, following a successful series A round of £9 million ($12.3M) [...]

From magnetic tape to the “DNA hard drive:” entering the next frontier with DNA data storage

Little did you know that the fate of the cute cat videos you post on Facebook is on magnetic tape stored at the bottom of a long, dark corridor in a data warehouse in California’s central valley. But the tapes [...]

Synvitrobio Rebrands as Tierra Biosciences, Announces $2.6M Seed Round to Discover Unexplored Areas of Biology

Louis Metzger, Ph.D. joins as Chief Scientific Officer September 11, 2018 01:58 PM Eastern Daylight Time SAN FRANCISCO--(BUSINESS WIRE)--Synvitrobio, the leader in cell-free natural product discovery, announced the closure of an oversubscribed $2.6 million seed funding round, led by [...]

ATUM and ADM Extend Joint Development Agreement

September 06, 2018 12:00 PM Eastern Daylight Time NEWARK, Calif.--(BUSINESS WIRE)--Bioengineering company ATUM announces today that it has extended its 2014 agreement with Archer Daniels Midland Company (NYSE: ADM) to apply ATUM’s proprietary bioengineering technology and gene engineering platform [...]